Atara Biotherapeutics (ATRA) CAPEX/Revenue US GAAP (year values)

2019 2020 2021 2022 2023   LTM ? CAGR 5 years ?
CAPEX/Revenue, % 52.0% 6.60% 14.3%   2.74%  
Changes by years, y/y, % -45pp +8pp     -47.6%

Atara Biotherapeutics. CAPEX/Revenue, %

Atara Biotherapeutics. CAPEX/Revenue, changes, pp

Atara Biotherapeutics (ATRA) CAPEX/Revenue US GAAP (quarter values)

2023Q1 2023Q2 2023Q3 2023Q4 2024Q1   LTM ?
CAPEX/Revenue, % 32.5% 52.1% 13.1% 1.03% 0.46%   2.74%
Changes by years, y/y, % -3pp +49pp +10pp -16pp -32pp    
Changes by quarters, q/q, % +16pp +20pp -39pp -12pp -1pp    

Atara Biotherapeutics. CAPEX/Revenue, %

Atara Biotherapeutics. CAPEX/Revenue, changes, pp

Atara Biotherapeutics. CAPEX/Revenue, changes, pp